These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15937641)

  • 41. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
    Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
    Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance.
    Davidovich IA; Levenson AS; Levenson Chernokhvostov VV
    Cancer Lett; 2004 Aug; 211(2):189-97. PubMed ID: 15219942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival.
    Martinez A; Bellosillo B; Bosch F; Ferrer A; Marcé S; Villamor N; Ott G; Montserrat E; Campo E; Colomer D
    Am J Pathol; 2004 Feb; 164(2):501-10. PubMed ID: 14742256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survivin promotes cell proliferation in human hepatocellular carcinoma.
    Ito T; Shiraki K; Sugimoto K; Yamanaka T; Fujikawa K; Ito M; Takase K; Moriyama M; Kawano H; Hayashida M; Nakano T; Suzuki A
    Hepatology; 2000 May; 31(5):1080-5. PubMed ID: 10796883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
    Nawrocki ST; Carew JS; Douglas L; Cleveland JL; Humphreys R; Houghton JA
    Cancer Res; 2007 Jul; 67(14):6987-94. PubMed ID: 17638911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factor.
    Wagner M; Schmelz K; Dörken B; Tamm I
    Int J Cancer; 2008 Mar; 122(6):1278-87. PubMed ID: 18027854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
    Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
    Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
    Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
    Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogenic c-H-ras deregulates survivin expression: an improvement for survival.
    Sommer KW; Rodgarkia-Dara CJ; Schreiner C; Holzmann K; Krupitza G; Cerni C
    FEBS Lett; 2007 Oct; 581(25):4921-6. PubMed ID: 17904124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):773-8. PubMed ID: 16525657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coexpression of survivin and PCNA in pituitary tumors and normal pituitary.
    Wasko R; Waligorska-Stachura J; Jankowska A; Warchol JB; Liebert W; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(4):477-81. PubMed ID: 20010504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of p16 and Survivin in gliomas and their correlation with cell proliferation.
    Gao Y; Li L; Song L
    Oncol Lett; 2015 Jul; 10(1):301-306. PubMed ID: 26171019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum survivin increases in prolactinoma.
    Dellal FD; Niyazoglu M; Gorar S; Ademoglu E; Candan Z; Bekdemir H; Hacioglu Y; Kaya FO
    J Clin Med Res; 2015 Apr; 7(4):248-52. PubMed ID: 25699121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.